Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;45(7):825-30.
doi: 10.1038/ng.2646. Epub 2013 May 26.

Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1

Gemma L Carvill  1 , Sinéad B Heavin, Simone C Yendle, Jacinta M McMahon, Brian J O'Roak, Joseph Cook, Adiba Khan, Michael O Dorschner, Molly Weaver, Sophie Calvert, Stephen Malone, Geoffrey Wallace, Thorsten Stanley, Ann M E Bye, Andrew Bleasel, Katherine B Howell, Sara Kivity, Mark T Mackay, Victoria Rodriguez-Casero, Richard Webster, Amos Korczyn, Zaid Afawi, Nathanel Zelnick, Tally Lerman-Sagie, Dorit Lev, Rikke S Møller, Deepak Gill, Danielle M Andrade, Jeremy L Freeman, Lynette G Sadleir, Jay Shendure, Samuel F Berkovic, Ingrid E Scheffer, Heather C Mefford
Affiliations

Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1

Gemma L Carvill et al. Nat Genet. 2013 Jul.

Abstract

Epileptic encephalopathies are a devastating group of epilepsies with poor prognosis, of which the majority are of unknown etiology. We perform targeted massively parallel resequencing of 19 known and 46 candidate genes for epileptic encephalopathy in 500 affected individuals (cases) to identify new genes involved and to investigate the phenotypic spectrum associated with mutations in known genes. Overall, we identified pathogenic mutations in 10% of our cohort. Six of the 46 candidate genes had 1 or more pathogenic variants, collectively accounting for 3% of our cohort. We show that de novo CHD2 and SYNGAP1 mutations are new causes of epileptic encephalopathies, accounting for 1.2% and 1% of cases, respectively. We also expand the phenotypic spectra explained by SCN1A, SCN2A and SCN8A mutations. To our knowledge, this is the largest cohort of cases with epileptic encephalopathies to undergo targeted resequencing. Implementation of this rapid and efficient method will change diagnosis and understanding of the molecular etiologies of these disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathogenic and likely pathogenic mutations identified in 500 patients with epileptic encephalopathies in novel genes (red) and known genes (blue)
Figure 2
Figure 2
De novo mutations in novel epileptic encephalopathy genes a) CHD2 and b) SYNGAP1. Mutations shown in red were identified in this study. Black entries denote previously reported variants; for CHD2, in ID (Thr604Leufs*19) and autism (Asp856Gly) and for SYNGAP1 in ID and/or autism, –. Bold entries indicate pathogenic variants found in patients with epilepsy. No evident genotype-phenotype correlations exist for mutations in either CHD2 or SYNGAP1. For both genes, truncating and missense mutations occur in all three phenotypes (ID/epileptic encephalopathy /autism) without phenotype-specific intragenic localization. This suggests that alternative neurobiological conditions and mechanisms, genetic or otherwise, underlie this heterogeneity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Berg AT, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology 2005–2009. Epilepsia. 2010;51:676–685. - PubMed
    1. Kamien BA, Cardamone M, Lawson JA, Sachdev R. A genetic diagnostic approach to infantile epileptic encephalopathies. J. Clin. Neurosci. 2012;19:934–941. - PubMed
    1. Mefford HC, et al. Rare copy number variants are an important cause of epileptic encephalopathies. Ann. Neurol. 2011;70:974–985. - PMC - PubMed
    1. Heinzen EL, et al. Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. Am. J Hum. Genet. 2010;86:707–718. - PMC - PubMed
    1. Capelli LP, et al. Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency. Eur. J. Med. Genet. 2012;55:132–134. - PubMed

Publication types